Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14 Gastrointestinal 9 Head & Neck 4 Thoracic 1 Other 1 Gynecologic 1 Endocrine 1 Dermatologic 1

Conditions

Pituitary Neoplasms 15 Neuroendocrine Tumors 15 Multiple Endocrine Neoplasia Type 1 9 Inflammation 4 Acromegaly 4 Sexual Dysfunction, Physiological 3 Pheochromocytoma 3 Obesity 3 Neoplasms 3 Gastro-enteropancreatic neuroendocrine tumor 3 Thyroid Cancer, Papillary 2 Prostatic Neoplasms 2 Pituitary Diseases 2 Paraganglioma 2 Carcinoid Tumor 2 Adrenal Gland Neoplasms 2 Zollinger-Ellison Syndrome 1 Vitamin D Deficiency 1 Serotonin Syndrome 1 Pituitary ACTH Hypersecretion 1 Pancreatic Neuroendocrine Tumors 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain 1 Neuroendocrine Tumour With Carcinoid Symptoms 1 Multiple Endocrine Neoplasia 1 Meningioma 1 Melanoma 1 Medulloblastoma 1 Lung Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Pain, Postoperative × Endocrine × Clear all

NCT06353529 2026-03-12

POPPY

Hamilton Health Sciences Corporation

Phase 4 Recruiting

Pain, Postoperative, Pituitary Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡